Author

Hendrik C. Peters

University of Utah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Amarnath NatarajaniD· 1 shared Carrie Winship· 1 shared Danielle Alvarado· 1 shared Kasidy K. Dobish· 1 shared R. Katherine HydeiD· 1 shared Shannon M. BuckleyiD· 1 shared Suchita Vishwakarma· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amarnath NatarajanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 13, 2024

Small molecule targeting of FBXO21 mediated p85αubiquitylation in acute myeloid leukemia

Kasidy K. Dobish, Suchita Vishwakarma, Hendrik C. Peters…·Shannon M. Buckley

The paper identifies FBXO21 as a therapeutic target in AML by developing a small molecule that inhibits p85 ubiquitination, reducing PI3K pathway activity and inducing cell death.

DOI 10.1101/2024.12.13.628427

humanproteomics

𝕏 PostBluesky